[
  {
    "ts": null,
    "headline": "Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?",
    "summary": "PFE's oncology portfolio, boosted by Seagen and late-stage pipeline assets, may fuel growth amid lackluster stock performance.",
    "url": "https://finnhub.io/api/news?id=2885992d608d46e02781df583c8263646f5419f5610aeaf38b0f0270bf210e57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750340820,
      "headline": "Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?",
      "id": 135396878,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PFE's oncology portfolio, boosted by Seagen and late-stage pipeline assets, may fuel growth amid lackluster stock performance.",
      "url": "https://finnhub.io/api/news?id=2885992d608d46e02781df583c8263646f5419f5610aeaf38b0f0270bf210e57"
    }
  },
  {
    "ts": null,
    "headline": "How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks",
    "summary": "The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",
    "url": "https://finnhub.io/api/news?id=fa9a93e95c5053f38bb921b4710481d5cce686998a56d37faeddc323e15586d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750338602,
      "headline": "How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks",
      "id": 135396436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",
      "url": "https://finnhub.io/api/news?id=fa9a93e95c5053f38bb921b4710481d5cce686998a56d37faeddc323e15586d8"
    }
  },
  {
    "ts": null,
    "headline": "Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals Stocks",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Royalty Pharma (NASDAQ:RPRX) and the best and worst performers in the branded pharmaceuticals industry.",
    "url": "https://finnhub.io/api/news?id=5b323eeaea899fb8ef7aa749afc0ecb414febe398fecb20c815b3e1f5265edb8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750304374,
      "headline": "Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals Stocks",
      "id": 135414052,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Royalty Pharma (NASDAQ:RPRX) and the best and worst performers in the branded pharmaceuticals industry.",
      "url": "https://finnhub.io/api/news?id=5b323eeaea899fb8ef7aa749afc0ecb414febe398fecb20c815b3e1f5265edb8"
    }
  }
]